Lumiracoxib inhibits cyclooxygenase 2 completely at the 50 mg dose: is liver toxicity avoidable by adequate dosing?
Aufgrund von Vorbereitungen auf eine neue Version von KOPS, können derzeit keine Publikationen eingereicht werden. (Due to preparations for a new version of KOPS, no publications can be submitted currently.)
| Type of Publication: | Journal article |
| Author: | Hinz, Burkhard; Renner, Britta; Cheremina, Olga; Besz, Dominika; Zolk, Oliver; Brune, Kay |
| Year of publication: | 2009 |
| Published in: | Annals of the Rheumatic Diseases ; 68 (2009), 2. - pp. 289-291 |
| Subject (DDC): | 150 Psychology |
| Bibliography of Konstanz: | Yes |
Cite This
Files in this item
| Files | Size | Format | View |
|---|---|---|---|
|
There are no files associated with this item. |
|||
HINZ, Burkhard, Britta RENNER, Olga CHEREMINA, Dominika BESZ, Oliver ZOLK, Kay BRUNE, 2009. Lumiracoxib inhibits cyclooxygenase 2 completely at the 50 mg dose: is liver toxicity avoidable by adequate dosing?. In: Annals of the Rheumatic Diseases. 68(2), pp. 289-291
@article{Hinz2009Lumir-1410, title={Lumiracoxib inhibits cyclooxygenase 2 completely at the 50 mg dose: is liver toxicity avoidable by adequate dosing?}, year={2009}, number={2}, volume={68}, journal={Annals of the Rheumatic Diseases}, pages={289--291}, author={Hinz, Burkhard and Renner, Britta and Cheremina, Olga and Besz, Dominika and Zolk, Oliver and Brune, Kay} }
<rdf:RDF xmlns:dcterms="http://purl.org/dc/terms/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:bibo="http://purl.org/ontology/bibo/" xmlns:dspace="http://digital-repositories.org/ontologies/dspace/0.1.0#" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:void="http://rdfs.org/ns/void#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" > <rdf:Description rdf:about="https://kops.uni-konstanz.de/rdf/resource/123456789/1410"> <dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/rdf/resource/123456789/43"/> <dc:creator>Hinz, Burkhard</dc:creator> <dc:contributor>Zolk, Oliver</dc:contributor> <dcterms:available rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2011-03-23T09:25:10Z</dcterms:available> <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2011-03-23T09:25:10Z</dc:date> <dc:creator>Renner, Britta</dc:creator> <dc:contributor>Hinz, Burkhard</dc:contributor> <dc:contributor>Cheremina, Olga</dc:contributor> <dc:contributor>Brune, Kay</dc:contributor> <dcterms:issued>2009</dcterms:issued> <dc:creator>Besz, Dominika</dc:creator> <dc:creator>Zolk, Oliver</dc:creator> <bibo:uri rdf:resource="http://kops.uni-konstanz.de/handle/123456789/1410"/> <foaf:homepage rdf:resource="http://localhost:8080/jspui"/> <dc:rights>terms-of-use</dc:rights> <dcterms:title>Lumiracoxib inhibits cyclooxygenase 2 completely at the 50 mg dose: is liver toxicity avoidable by adequate dosing?</dcterms:title> <dc:creator>Brune, Kay</dc:creator> <dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/rdf/resource/123456789/43"/> <dc:contributor>Besz, Dominika</dc:contributor> <dcterms:rights rdf:resource="https://rightsstatements.org/page/InC/1.0/"/> <dc:creator>Cheremina, Olga</dc:creator> <void:sparqlEndpoint rdf:resource="http://localhost/fuseki/dspace/sparql"/> <dcterms:bibliographicCitation>Publ. in: Annals of the Rheumatic Diseases, 68 (2009), 2, pp. 289-291</dcterms:bibliographicCitation> <dc:contributor>Renner, Britta</dc:contributor> <dc:language>eng</dc:language> </rdf:Description> </rdf:RDF>
This item appears in the following Collection(s)
Search KOPS
Browse
My Account
